-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Initiates Coverage On BrightSpring Health with Buy Rating, Announces Price Target of $71

Benzinga·06/08/2026 17:11:29
Listen to the news
Goldman Sachs analyst Scott Fidel initiates coverage on BrightSpring Health (NASDAQ:BTSG) with a Buy rating and announces Price Target of $71.